Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by CIBC Asset Management Inc

CIBC Asset Management Inc lifted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 9.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,578 shares of the biotechnology company's stock after acquiring an additional 895 shares during the period. CIBC Asset Management Inc's holdings in Axon Enterprise were worth $4,227,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. PFG Investments LLC lifted its position in shares of Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company's stock valued at $1,547,000 after buying an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC grew its position in shares of Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company's stock valued at $656,000 after purchasing an additional 26 shares in the last quarter. Mather Group LLC. increased its holdings in shares of Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company's stock worth $303,000 after purchasing an additional 27 shares during the period. CWM LLC raised its holdings in shares of Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company's stock valued at $1,141,000 after acquiring an additional 36 shares in the last quarter. Finally, SPC Financial Inc. raised its stake in Axon Enterprise by 2.2% in the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company's stock valued at $708,000 after purchasing an additional 38 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded up $10.20 on Tuesday, hitting $610.20. 979,345 shares of the company traded hands, compared to its average volume of 553,311. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business has a 50-day simple moving average of $448.52 and a 200 day simple moving average of $361.95. Axon Enterprise, Inc. has a 52 week low of $224.16 and a 52 week high of $624.84. The stock has a market capitalization of $46.53 billion, a P/E ratio of 157.67, a price-to-earnings-growth ratio of 15.05 and a beta of 0.94.

Insider Activity at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the company's stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company's stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 25,811 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares of the company's stock, valued at $82,103,253.44. The trade was a 10.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 411,006 shares of company stock worth $161,360,618 in the last quarter. 5.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Barclays boosted their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Robert W. Baird boosted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an "outperform" rating in a report on Monday, November 4th. Craig Hallum upped their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a research note on Wednesday, August 7th. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Finally, Northland Securities boosted their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research report on Monday, November 11th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of "Moderate Buy" and an average target price of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.